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Abstract
The purpose of this study was to investigate the relationship between birth weight and appetite related hormones, insulin resistance, and antioxidant
status in overweight children aged 9-10 years. Thirty-four healthy overweight children (18 boys, 16 girls) were evaluated with respect to anthropometric
measurement, lipid profiles, leptin, ghrelin, glucose, insulin, C-peptide, lipid soluble vitamins, and antioxidant enzyme activities. I found that birth 
weight was negatively correlated with insulin resistance parameters, ghrelin, and coenzyme Q10 levels. There was a significant positive correlation
between present BMI and leptin level, while a negative correlation was noted between the BMI and α-tocopherol and lycopene levels. When total
subjects were classified into three groups by tertiles of birth weight, the lowest tertile of birth weight (LTB) group showed higher levels of fasting 
glucose, HOMA-IR, and ghrelin level than the highest tertile of birth weight (HTB) groups. On the other hand, HTB group showed an increased
oxidative stress (decreased coenzyme Q10 level and catalase activity) compared to the LTB group. In conclusion, plasma ghrelin level might play 
an important role in accelerated growth in overweight children with LTB. Increased insulin resistance is present in overweight children with LTB,
while decreased coenzyme Q10 and catalase activity in overweight children with HTB. These results suggest that birth weight might be an important
factor for determination of treatment for obesity related complications in childhood obesity.
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Introduction8)
The increasing prevalence of childhood obesity is a major 
health problem worldwide, because excessive bodyweight is a 
risk factor for future development of chronic diseases such as 
cardiovascular disease and type 2 diabetes mellitus [1]. The 
incidence of obesity in the 10-18 year old population has been 
increasing in Korea from 5.4% in 1998 to 11.3% in 2001 along 
with increased risks for cardiovascular disease (e.g. hypertension 
and hyperlipidemia) [2].
Epidemiological studies have shown that intrauterine growth 
pattern, weight at birth, early postnatal catch-up growth, and 
excess childhood weight gain are associated with an increased 
risk of adult cardiovascular disease and type 2 diabetes [3]. 
Higher birth weight is positively associated with subsequent 
greater body mass index, mostly lean mass in childhood and later 
life, while lower birth weight is associated with subsequent higher 
ratio of fat mass to lean mass [4,5]. 
Several studies have shown that birth weight is an important 
risk factor for insulin resistance which has multifactorial 
pathogenesis and is associated with cardiovascular risk, diabetes, 
hypertension, and a short lifespan [3,6,7]. Children born small 
or large for gestational age have an increased risk of insulin 
resistance, although the mechanisms underlying may be different 
between the cases [8,9]. Interestingly oxidative stress, a state of 
imbalance between the formation of oxygen free radicals and 
antioxidant defense system, is reported to be tightly linked to 
birth weight [10-12]. 
Recently, birth weight is reported to have a significant effect 
on the ghrelin level, a major orexigenic hormone [13]. Ghrelin, 
a 28 amino acid peptide, is predominantly produced in the gastric 
fundus which increases the sense of hunger and stimulates gastric 
emptying [14]. Ghrelin has a role in short-term regulation of 
energy homeostasis and also in long-term regulation of energy 
balance and body weight control [15]. Many studies have found 
that plasma ghrelin levels are lower in obese subjects than in 
normal weight subjects [16-18]. Darendeliler et al. [13] reported 
that non-obese prepubertal children born large for gestational age 
have lower ghrelin levels when compared with age and BMI 
matched appropriate for gestational age children.
However, there are no studies concerning the effect of birth 
weight on ghrelin levels in overweight/obese children who has 
altered metabolic state compared to the normal weight children. 
Therefore, I investigated primarily ghrelin levels according to 
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birth weight and also the relationship between birth weight and 
insulin resistance as well as antioxidant status in overweight 
children.
Subjects and Methods
Subjects
Thirty-four healthy overweight children aged 9-10 years (18 
boys, 16 girls) participated in this study. Body weight and height 
were measured and body mass index (BMI) was calculated. 
Blood pressure was measured by a standard brachial cuff 
technique. Child overweight was defined more than 85
th 
percentile of BMI according to appropriate BMI cutoff point for 
age and sex using Korean growth charts [19,20]. All children 
were born at term between 39
th and 41
th weeks of gestation. Their 
birth weight was answered by their parent and confirmed from 
their birth certificate card. No complication during pregnancy 
was reported. Venous blood samples were obtained from the 
forearm and collected into EDTA-treated and plain tubes during 
fasting. To further investigate the association between birth 
weight and insulin resistance, appetite related hormones, and 
antioxidant status, subjects were classified into three groups by 
tertiles of birth weight. Written informed consent was obtained 
from the children and their parents. The study was conducted 
in compliance with the "Ethical principles for medical research 
involving human subjects" of  Helsinki Declaration [21].
Plasma lipid profiles, leptin, and ghrelin
Plasma total cholesterol and triglyceride were measured with 
commercially available kits (Choongwae, Seoul, Korea) by 
enzymatic methods. All determinants were done on a Hitachi 
747 autoanalyzer (Hitachi, Tokyo, Japan). Radioimmunoassay 
was used to measure the plasma leptin concentrations using 
Packard Cobra II 5005 γ-Counter with Human Leptin RIA kit 
(Linco Research, St Charles, MO, USA). Total plasma ghrelin 
concentration was measured by radioimmunoassay (Phoenix 
Pharmaceutical, Belmont, CA, USA).
Serum glucose, insulin, C-peptide, and HOMA
Fasting serum concentrations of glucose was measured by a 
glucose oxidase method using a Beckman Glucose Analyzer 
(Beckman Instruments, Irvine, CA, USA). Insulin was measured 
by radioimmunoassay with commercial kits from Immuno Nucleo 
Corporation (Stillwater, MN, USA). C-peptide was measured by 
radioimmunoassay from Diagnostic Systems Laboratories 
(Diagnostic Systems Laboratories, Webster,  TX,  USA). I 
measured insulin resistance using the homeostasis model, in 
which insulin resistance (HOMA-IR) = fasting insulin (μU/ml) 
× glucose (mmol/L)/22.5 [22].
Plasma lipid-soluble vitamins
Plasma concentrations of retinol, carotenoids, tocopherols and 
coenzyme Q10 were determined simultaneously by reversed-phase 
high-pressure liquid chromatography (RP-HPLC) according to 
the method of Jakob and Elmadfa [23]. Briefly, plasma proteins 
were precipitated with ethanol and lipids were extracted with 
n-hexane. After evaporation, dry residue was redissolved with 
150 μl of methanol-dichlormethane (85:15, v/v) and mixed and 
then 100 μl of this solution was injected into a guard column 
[Merck LiChrospher 100 RP18 (10 µm), 250 × 4 mm]. Samples 
were run at a flow rate of 1.0 ml/min on a Dionex HPLC system 
(Summit
TM HPLC, USA). Absorption was monitored at 325 nm 
for retinol, at 295 nm for tocopherols, at 450 nm for carotenoids, 
and at 270 nm for coenzyme Q10. Concentrations were calculated 
from areas under the curve using an external calibration curve.
Erythrocyte antioxidant enzyme activities 
GSH-Px was determined according to the method described 
by Beutler [24]. Erythrocytic hemolysate 10 μl preparation was 
added to 100 μl of 1 M Tris-HCI 5 mM EDTA buffer (pH 8.0), 
20 μl of glutathione 0.1 M, 100 μl of glutathione reductase 10 
U/ml, and 100 μl of NADPH 2 mM, and filled with H2O to 
a final volume of 1 ml. After 10 min of incubation at 37 ℃, 
the reaction was initiated by the addition of 10 μl of t-butyl 
hydroperoxide, and the absorbance was measured at 340 nm. The 
reaction was run for 90 s, and the loss of NADPH was monitored 
by the change in A340nm/min. Catalase activity was measured 
according to the method developed by Aebi [25]. Erythrocytic 
hemolysate 100 μl was dissolved in 50 mM phosphate buffer 
50 ml (pH 7), and 2 ml of the mixture was added to a cuvette. 
The reaction was initiated by the addition of 1 ml of 30 mM 
H2O2 at 20℃. The H2O2 decomposition rate was measured at 
240 nm for 30 s using a spectrophotometer. The SOD activity 
was assayed in erythrocyte-suspension by the procedure of 
Marklund and Marklund [26]. To 500 μl of the hemolysate were 
added 3.5 ml of water, 1 ml of ethanol and 0.6 ml chloroform. 
After the centrifugation at 3,000 IU/min for 2 min, various 
dilutions were prepared from the supernatant. 20 μl pyrogallol 
was added to each dilution after incubation at 37℃ for 10 min. 
The reaction was monitored spectrophotometrically at 320 nm 
for 2 min. The unit of the enzyme was defined as the amount 
which inhibits the autoxidation of pyrogallol by 50%. The 
hemoglobin contents of the erythrocytic hemolysates were 
determined using the kit assay (Boehringer Mannheim, Germany).
Statistical analysis 
The SPSS 14.0 software package was used for statistical 
analysis. Data are presented as mean ± SD. All variables were 
examined for normal distribution as tested by Kolmogorov- 
Smirnov test and non-normally distributed variables were Eunju Park 313
Table 1. Characteristics of the subjects
Variables Boys (n = 18) Girls (n = 16)
Birth weight (kg) 3.44 ± 0.55
  3.35 ± 0.21
At investigation
Age (yr) 9.6 ± 0.5 9.6 ± 0.5
Weight (kg) 44.0 ± 4.3 42.4 ± 6.6
Height (cm) 140.2 ± 4.7 139.4 ± 6.3
BMI (kg/m
2) 22.3 ± 1.5 21.7 ± 2.3
Systolic blood pressure (mm/Hg) 111.7 ± 6.2 110.7 ± 8.8
Diastolic blood pressure (mm/Hg) 71.1 ± 5.8 69.3 ± 7.0
HOMA-IR 1.87 ± 1.14 1.59 ± 0.79
Leptin (ng/ml) 9.9 ± 4.3 9.3 ± 4.2
Ghrelin (ng/ml) 3.29 ± 2.10 2.61 ± 1.24
Values  are  mean ± SD.
BMI: Body mass index, HOMA-IR: homeostasis model assessment-insulin resistance 
calculated  as  fasting  insulin  (μU/ml) × glucose  (mmol/L)/22.5
Table 2. Correlation coefficient of birth weight and present BMI with parameters
of insulin resistance and antioxidant status (n = 34)
Variables Birth weight Present BMI
Present BMI 0.06
Glucose  -0.36* 0.24
Insulin -0.31 0.15
HOMA-IR  -0.40* 0.22
C-peptide -0.34 0.12
Leptin 0.24 0.63***
Ghrelin  -0.35* -0.33
Retinol -0.31 0.01
γ-tocopherol -0.22 -0.14
α-tocopherol -0.11  -0.41*
Lycopene 0.03  -0.36*
α-carotene 0.06 -0.17
β-carotene -0.09 -0.30
Coenzyme Q10  -0.36* 0.28
Superoxide dismutase 0.11 0.04
Catalase -0.25 -0.21
Gluthatione perxoidase 0.12 0.19
BMI: Body mass index, HOMA-IR: homeostasis model assessment-insulin resistance 
calculated  as  fasting  insulin  (μU/ml)  ×  glucose  (mmol/L)/22.5
* P < 0.05,  *** P < 0.005
Table 3. Comparison of clinical parameters based on the tertiles of birth weight 
in over-weight children
Variables LTB (n = 11) MTB (n = 12) HBT (n = 11)
Boys/girls (n) 7/4 4/8 7/4
Birth weight (kg) 2.98 ± 0.20
a 3.40 ± 0.08
b 3.81 ± 0.40
c
At investigation
Age (yr) 9.5 ± 0.5 9.6 ± 0.5 9.7 ± 0.5
Weight (kg) 43.8 ± 6.9 42.3 ± 4.3 43.7 ± 5.3
Height (cm) 139.8 ± 6.4 139.0 ± 4.7 140.8 ± 5.4
BMI (kg/m
2) 22.3 ± 2.2 21.9 ± 1.8 22.0 ± 1.9
Glucose (mg/dl) 95.0 ± 14.3
b 82.5 ± 10.8
a 83.1 ± 11.0
a
Insulin (μU/ml) 9.7 ± 4.3 7.4 ± 3.7 7.2 ± 4.3
HOMA-IR 2.33 ± 1.12
b 1.50 ± 0.78
a 1.45 ± 0.89
a
C-peptide (ng/ml) 1.50 ± 0.30 1.28 ± 0.43 1.31 ± 0.37
Leptin (ng/ml) 9.4 ± 6.0 9.3 ± 3.7 10.1 ± 3.2
Values  are  mean ± SD. 
LTB: Lowest tertile of birth weight, MTB: Mid tertile of birth weight, HTB: Highest 
tertile  of  birth  weight
Values in the same row with different superscripts are significantly different (P<0.05).
BMI: Body mass index, HOMA-IR: homeostasis model assessment-insulin resistance 
calculated  as  fasting  insulin  (μU/ml) × glucose  (mmol/L)/22.5
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Fig. 1. Comparison of plasma ghrelin concentrations according to the tertiles 
of birth weight in overweight subjects. Values are mean ± SD. LTB: Lowest tertile 
of birth weight, MTB: Mid tertile of birth weight, HTB: Highest tertile of birth weight. 
Means with common superscripts indicate that the difference between means is no 
significant  (P < 0.05).
log-transformed. For descriptive purposes, mean values are 
presented on untransformed variables. I used normalized 
antioxidant vitamin values which were corrected for the sum of 
plasma cholesterol (mg/dl) and triglyceride (mg/dl) because of 
their interdependency in circulation as suggested by Thurnham 
et al. [27] and Horwitt et al. [28]. I used the Pearson correlation 
coefficient to evaluate the relationships of the variables. 
Differences in continuous variables among the tertiles of birth 
weight levels were evaluated by one-way ANOVA followed by 
the Bonferroni method. Values of P < 0.05 were considered to 
be significant.
Results
The clinical characteristics of the 34 overweight children (9-10 
years) are summarized in Table 1. There was no significant 
difference in birth weight, anthropometric data, blood pressure, 
and hormone levels (HOMA-IR, leptin, and ghrelin) at investigation, 
according to sex.
Table 2 shows the relationship of birth weight and BMI at 
investigation to the levels of insulin resistance parameters, 
appetite related hormones, and the levels of plasma antioxidant 
vitamins and erythrocytic antioxidant enzyme activities in 
overweight children. Birth weight was negatively correlated with 
insulin resistance parameters (fasting glucose, HOMA-IR) and 
also with ghrelin and coenzyme Q10 levels. There was a 
significant positive correlation between present BMI and leptin 
level, while a negative correlation was noted between BMI and 
α-tocopherol and lycopene levels. No significant relations were 
observed between plasma ghrelin and other analyzed parameters 
(data not shown).
To further investigate the association between birth weight and 
present body size, insulin resistance, appetite related hormones, 
and antioxidant status, 34 overweight children were classified 
into three groups by tertiles of birth weight. There were no 
significant differences in body weight, height, or BMI at 
investigation (Table 3) among three groups. I found that the 314 Birth weight and plasma ghrelin in overweight children
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Fig. 2. Comparison of plasma coenzyme Q10 concentrations according to the 
tertiles of birth weight in overweight subjects. LTB: Lowest tertile of birth weight, 
MTB: Mid tertile of birth weight, HTB: Highest tertile of birth weight. Values are mean
± SD.  Means  with  common  superscripts  indicate  that  the  difference  between 
means  is  no  significant  (P < 0.05).
Table 4. Comparison of clinical parameters based on the tertiles of birth weight 
in over-weight children
Variables LTB (n = 11) MTB (n = 12) HTB (n = 11)
Plasma
Retinol (μg/dl) 0.21 ± 0.04 0.22 ± 0.04 0.20 ± 0.06
α-tocopherol (μg/dl) 7.3 ± 1.6 6.9 ± 1.0 6.7 ± 1.8
Lycopene (μg/dl) 0.12 ± 0.03 0.12 ± 0.07 0.13 ± 0.06
α-carotene (μg/dl) 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01
β-carotene (μg/dl) 0.29 ± 0.25 0.36 ± 0.20 0.23 ± 0.15
Erythrocyte enzyme activity
Superoxide dismutase 
(U/g Hb)
1091.2 ± 297.1 1200.7 ± 451.1 1023.4 ± 226.6
Catalase (K/g Hb) 283.5 ± 33.6
b 286.7 ± 44.3
b 250.8 ± 33.9
a
Gluthatione perxoidase 
(U/g Hb)
33.5 ± 10.9 35.0 ± 8.1 34.4 ± 10.4
Values  are  mean ± SD. 
LTB: Lowest tertile of birth weight, MTB: Mid tertile of birth weight, HTB: Highest 
tertile of birth  weight
Values  in  the  same row with different superscripts are significantly different (P <
0.05).
lowest tertile of birth weight (LTB) group showed higher levels 
of fasting glucose level and HOMA-IR than mid (MTB) or 
highest tertile of birth weight (HTB) groups. As shown in Fig. 
1, LTB group showed higher level of plasma ghrelin than in 
the highest group. As for the effect of birth weight on the present 
antioxidant status, lipid corrected coenzyme Q10 level was 
significantly lower in the HTB group than in the LTB group 
(Fig. 2). In addition, the lowest catalase activity in erythrocytes 
was found in the HTB group compared to the mid or lowest 
groups (Table 4).
Discussion
The purpose of this study was to investigate the relationship 
between birth weight and appetite related hormones, insulin 
resistance, and antioxidant status in overweight children aged 
9-10 years. It is well known that ghrelin level correlates inversely 
with adiposity at baseline [15], demonstrating that ghrelin level 
was increased in anorexia and cachexia [29], while decreased 
in obese subjects [16,17]. Interestingly, some studies reported 
that ghrelin is shown to correlate more significantly with body 
weight at birth than current body weight [30]. In accordance with 
these studies, the significant negative relationship could be found 
between plasma ghrelin and birth weight (BW) (r = -0.35, P <
0.05), but not between ghrelin and current BMI in overweight 
children in this study. Darendeliler et al. [13] demonstrated that 
plasma ghrelin level was significantly lower in appropriate for 
gestational age (AGA, BW: 3.12 ± 0.49 kg) than in large for 
gestational age (LGA, BW: 3.97 ± 0.52 kg) in non-obese children 
aged 4.4 ± 0.3 years. Most studies used percentile for gestational 
age of population-based birth weight (small for gestational age, 
SGA: < 10 percentile, AGA: between 10 and 90 percentile, LGA: 
> 90 percentile) as the cut off criteria of birth weight. When 
I applied that cut off criteria for Korean [31] in this study, 
however, only two or three children were allocated to SGA or 
LGA group which made hard to find any significance between 
the groups. Therefore, I classified the subjects into three groups 
by tertiles of birth weight. In accordance with Darendeliler et 
al. [13], I also found that overweight children with the LTB (2.98
± 0.20 kg), which is similar to AGA BW in the above mentioned 
study, had significantly higher ghrelin levels than those with the 
HTB (3.81 ± 0.40 kg) at similar BMI levels. Ghrelin is known 
to be present in human fetal circulation from 20
th weeks to term 
[32] and unchanged from birth to young adult [33]. From these 
findings including my results, it could be implied that the 
decreased levels of ghrelin in LGA born children either 
non-obese or overweight may play a physiological role in fetal 
adaptation to intrauterine milieu and also in the regulation of 
body weight in childhood. On the other hand, In ˜iguez et al. [34] 
have reported that higher ghrelin levels were seen in SGA infants 
who showed greater infancy weight gain during the first year 
of life, suggesting that sustained orexigenic drive by increased 
ghrelin could contribute to postnatal catch-up growth. High 
ghrelin in the newborn SGA may be an important factor favoring 
accumulation of fat in later years [35]. In this study the 
accelerated growth rate and fat accumulation driven by higher 
ghrelin levels in the children with the LTB group compared to 
those with mid or the highest tertile BW among overweight 
subjects is thought to be one of main reasons for being 
overweight 9-10 years after birth.
Leptin, another orexigenic hormone, however, is found not to 
be correlated with birth weight, but to be strongly correlated with 
the current body weight, indicating that the plasma concentration 
of leptin is affected by body fat, the main secretory organ of 
letpin.
According to Eyzaguirre and Mericq [36], birth weight is one 
of the important risk factor for insulin resistance. In children 
and adolescents, several studies have reported a U-shaped relation 
between birth weight and insulin resistance or type 2 diabetes 
[37,38]. In other words, reduced fetal growth has been shown 
to be associated with the increased risk of insulin resistance, 
obesity, cardiovascular disease, and type 2 diabetes, especially 
when accompanied by weight gain during early life [39]. Being Eunju Park 315
born large for gestational age has been also associated with an 
increased risk of insulin resistance [36]. In the present study, 
birth weight was also negatively correlated with plasma fasting 
glucose and HOMA-IR, a marker for insulin resistance, showing 
the significant increases in fasting glucose concentration and 
HOMA-IR in overweight children with the LTB than other 
groups. This finding is in agreement with previous data reported 
by Bouhours-Nouet et al. [40] who demonstrated that obese 
children with low birth weight (BW: 2.5 ± 0.4 kg) had higher 
HOMA-IR and lower muscle insulin sensitivity than those with 
high birth weight (BW: 4.3 ± 0.4 kg), and high weight gain after 
4 years was associated with lower insulin sensitivity, suggesting 
that low birth weight and no early catch-up weight have been 
associated with increased risks of insulin resistance from 
childhood onward and later type 2 diabetes and cardiovascular 
disease. Brufani et al. [41] have also found that SGA obese 
children showed higher glucose area under curve (AUC) and 
lower insulinogenic
  and disposition indexes, suggesting that 
obese children with low BW resulted in an adverse metabolic 
outcome compared to obese children with normal and high birth 
weight. 
A positive association between BMI and HOMA-IR in children 
and adolescents has been shown in several studies [42,43], while 
there was no correlation between current BMI and insulin 
resistance in the present study. The main reason for no correlation 
between two parameters might be due to the narrow BMI range, 
because the subjects in this study were limited to overweight.
Strauss [44] demonstrated that plasma levels of lipophilic 
antioxidants are significantly decreased in obese children. 
Increased expenditure and entrapment of lipophilic antioxidants 
in the adipose tissue have been reported in obesity [45]. It is 
also confirmed in this study that current BMI is negatively 
correlated with lipophilic antioxidant vitamin (α-tocopherol and 
lycopene) levels.
Regarding to the relationship between birth weight and 
oxidative stress, an increased hydroperoxide and carbonyl protein 
level, and decreased vitamin A and E have been recently reported 
in newborns with LGA (BW: 4.38 ± 0.07 kg) compared to those 
with AGA (BW: 3.29 ± 0.06 kg) [46]. Chiavaroli et al. [10] 
reported that LGA children regardless of their current weight 
showed higher levels of urinary isoprostane, a marker of 
oxidative stress, than AGA children. Similarly, I found here that 
overweight children with HTB had significantly decreased 
plasma coenzyme Q10, known as an effective inhibitor of 
oxidative damage in LDL, and erythrocyte catalase activity 
compared to those with LTB, indicating that the overweight 
children with higher BW showed increased oxidative stress. 
Based on these findings, it is speculated that overweight children 
born with higher birth weight might have altered metabolism of 
coenzyme Q 10 and catalase activity, which may contribute to 
the resulting risk of the complications (e.g. arteriosclerosis) 
related to obesity.
In summary, overweight children born full term with lower 
birth weight showed increased ghrelin levels and insulin 
resistance, while overweight children with higher birth weight 
experienced decreased coenzyme Q10 concentration and catalase 
activity. In addition, birth weight was negatively associated with 
ghrelin, insulin resistance, and coenzyme Q10 in overweight 
children. This study provides the evidences that birth weight 
might be an important factor for determination of treatment for 
obesity related complications in childhood obesity.
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